e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Sleep disorders: neurology, smoking and daytime sleepiness
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of nCPAP-therapy to depressive symptoms in patients with obstructive sleep apnea
J. Herold, J. Acker, K. Richter, A. Piehl, G. Niklewski, J. Ficker (Nuremberg, Germany)
Source:
Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Session:
Sleep disorders: neurology, smoking and daytime sleepiness
Session type:
Thematic Poster Session
Number:
950
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Herold, J. Acker, K. Richter, A. Piehl, G. Niklewski, J. Ficker (Nuremberg, Germany). Effect of nCPAP-therapy to depressive symptoms in patients with obstructive sleep apnea. Eur Respir J 2010; 36: Suppl. 54, 950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prevalence of depressive symptoms in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Correlation between the architecture of sleep and depressive symptoms in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Frequency of depression and anxiety in obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006
Residual obstructive sleep apnoea symptoms after adenotonsillectomy in children
Source: International Congress 2018 – Assessing pathophysiology in children
Year: 2018
Diagnosis of sleep-related breathing disorders and definition of hypopnoea and obstructive sleep apnoea severity
Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy
Year: 2018
Effects of oropharyngeal exercises on antropometric measures and symptoms in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment
Year: 2012
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
The familial occurrence of obstructive sleep apnoea symptoms
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017
Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Obstructive sleep apnea syndrome and insomnia: The development of insomnia symptoms with CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Gender-related differences in presenting symptoms of patients with obstructive sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006
Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006
The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006
Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003
Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept